Janus Henderson Group’s ProKidney PROK Stock Holding History

Janus Henderson Group’s Portfolio PROK Stock Details PROK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-18,793	Closed	-$86.2K	–	2597
2023 Q3	$86.2K	Sell	18,793 -87	-0.5%	-$833	﹤0.01%	2531
2023 Q2	$211K	Buy	+18,880	New	+$201K	﹤0.01%	2423

Other funds holding PROK

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Brown University Providence, Rhode Island $102M AUM 26.79% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Janus Henderson Group's PROK Position: Q4 2023 in Review

Janus Henderson Group sold out of ProKidney (PROK) in Q4 2023, closing a stake of 18,793 shares — an estimated $86.2K sold.

Janus Henderson Group first reported a position in PROK in Q2 2023 and held it in 2 quarters. The position peaked at $211K in Q2 2023. 61 funds tracked by Wall St. Rank hold PROK as of Q4 2023.

Janus Henderson Group reported no remaining ProKidney position as of Q4 2023 after selling out during the quarter.
Janus Henderson Group sold 18,793 ProKidney shares in Q4 2023, an estimated $86.2K.
Janus Henderson Group first reported a position in ProKidney in Q2 2023 and held it in 2 quarters.
Janus Henderson Group's ProKidney position peaked at $211K in Q2 2023.
61 funds tracked by Wall St. Rank held ProKidney as of Q4 2023.

Based on Janus Henderson Group's 13F filing for Q4 2023, filed 14 Feb 2024.